
Sexual Health
Latest News

Latest Videos

CME Content
More News

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study reveals that the mode of delivery, whether vaginal or cesarean, does not affect long-term sexual life satisfaction.

A recent study highlights that pelvic floor muscle training can enhance sexual function in women, with significant improvements in arousal, lubrication, and orgasm.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study found that topical sildenafil cream improves sexual arousal outcomes in women with female sexual arousal disorder, offering a potential new treatment option.

New data from Kaiser Permanente suggest teenagers with autism were 31% less likely to make any ob/gyn visit, and were up to 3-fold more likely to be diagnosed with a gynecologic condition.

A pair of studies from AUA 2024 show neither drinking nor vaping by either parent is associated with significantly increased risk of a spontaneous abortion.

New data show women of specific race and ethnicity may more be adversely affected by the changing state-level laws on abortion access.

Gynecologic providers should feel more comfortable proactively addressing the sexual well-being of their patients.

In a recent study, patients receiving Sildenafil Cream for female sexual arousal disorder reported improvements in arousal dysfunction.

In a recent review, a lack of education on female sexual medicine was found across medical institutions.

In a recent study, patients in the preconception period did not discuss sexual dysfunction and distress with health care professionals despite high prevalence.

Women with type 1 diabetes experience a three times greater risk of sexual dysfunction than women without diabetes.

At the 2023 ACOG Annual Clinical & Scientific Meeting, a study on how youth-led intervention to increase sexual health literacy can empower adolescents.

In a recent study, anxiety- and depression-related disorders were more common in women with polycystic ovary syndrome, chronic pelvic pain, and other reproductive disorders.

The new guidance is the first update since 2008, replacing the previous risk-based recommendations.

At the International Society for the Study of Women’s Sexual Health (ISSWSH) conference, held this year March 2 to 5 in St. Louis, Missouri, Contemporary OB/GYN®’s digital editor, Michael Krychman, MD, spoke with Ashley Tapscott, a board-certified urologist trained in male and female sexual dysfunction, who works in Charlotte, North Carolina.

Michael Krychman, MD, digital editor for Contemporary OB/GYN® recently attended the International Society for the Study of Women’s Sexual Health (ISSWSH), held March 2 through March 5 in St. Louis, Missouri. There he spoke to Andrew Goldstein, MD, a board-certified ob gyn who practices in Annapolis, Maryland and is the past president of ISSWSH.

Individuals that did not respond had a lower percentage of naïve T cells compared to responders, while responders had a lower percentage of Th2 and CD4 central memory subsets before vaccination.

Five water-based personal lubricants were found effective, safe, and well tolerated for the relief of discomfort from vaginal dryness, according to a recently published study.

A survey saw that of teenagers who sought care in the ED and were prescribed outpatient treatment, fewer than half who received an STI diagnosis filled their prescriptions.

Kenneth J. Tomecki, MD, discussed the clinical relevance of sexually transmitted diseases (STDs) to dermatology and outlined what to look for and how to treat various conditions at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

In this installment of Urology Times' 50th Anniversary Innovation Celebration, Rachel S. Rubin, MD, discusses the evolution in the treatment of female hypoactive sexual desire disorder.

Tracy MacNeal, president and CEO of Materna Medical, sits down to discuss the company's recently FDA-cleared Milli Vaginal Dilator for vaginismus and associated dyspareunia, as well as a potential new use for the device currently being studied.

Top takeaways from ISSWSH 2022